Ledger.Open graph →
SEC Form D · filed March 25, 2021

Kestrel Therapeutics Inc

Offering
$2.0M
Sold
$228K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WAYLAND, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Frank G. Haluska · Wayland, MAExec · DirectorThomas Q. Benedetti · RICHMOND, VAExec · DirectorErin Terjesen · Phoenix, AZExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗